Evonik Animal Nutrition to offer EuroTier visitors a free trial of PROXYMet™
At EuroTier 2018, November 13-16 (Hall 22, Booth C23) Evonik Animal Nutrition will promote its newest concept, PROXYMet™ designed to confirm the superior nutritional value of MetAMINO® versus methionine hydroxy analog.
PROXYMetTM allows customers, for the first time, to verify the results of published studies and trials at their own livestock operation without any need to change their feed formulation in use. With only 65 per cent of MetAMINO®, the same nutritional value is achieved as with 100 per cent MHA-FA.
“Switching completely to MetAMINO® makes it possible to achieve optimal results and realize lasting savings,” says Dr. Alfred Petri, Senior Vice President Sales Animal Nutrition. “And this is in addition to the other advantages of MetAMINO® – like ease of handling and improved mixability.”
Evonik will also showcase their probiotic products, Ecobiol® and Fecinor® with a scientific proven mode of action. Ecobiol® adds value by improving animal uniformity, performance and welfare of the flocks through optimized nutrient utilization.
At Evonik’s booth, visitors will also learn about AMINONIR® Advanced, Evonik’s service evolution for enhanced raw material analysis. Measuring unground samples at the point of delivery, the service improves handling and shortens time of analysis substantially. Claimed to be fast, accurate and reliable, it covers the most comprehensive number of feed ingredients in the industry.
Global Swine Expert Dr. John Htoo and Dr. Mario Müller will present on the ‘Potential and implementation of low protein diets in swine feeding’ at 3.30pm on November 13, DLG Pig Forum, Hall 16, Booth D26.
Visitors are invited to join the team for a prize draw to support Evonik’s corporate social responsibility project Utho Ngathi in South Africa. The project assists Eastern Cape Province communities through a home-based care programme and provides employment with the construction of new poultry housing and a greenhouse.
Evonik is one of the world leaders in specialty chemicals. The focus on more specialty businesses, customer-orientated innovative prowess and a trustful and performance-oriented corporate culture form the heart of Evonik’s corporate strategy. They are the lever for profitable growth and a sustained increase in the value of the company. Evonik benefits specifically from its customer proximity and leading market positions. Evonik is active in over 100 countries around the world with more than 36,000 employees. In fiscal 2017, the enterprise generated sales of €14.4 billion and an operating profit (adjusted EBITDA) of €2.36 billion.
About Nutrition & Care
The Nutrition & Care segment is led by Evonik Nutrition & Care GmbH and contributes to fulfilling basic human needs. That includes applications for everyday consumer goods as well as animal nutrition and health care. This segment employed about 7,500 employees, and generated sales of around
€4.3 billion in 2016.
In so far as forecasts or expectations are expressed in this press release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.